Bright Minds Biosciences (DRUG) Shares Outstanding (Weighted Average) (2020 - 2026)
For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 86983107.71% year-over-year to $266.7 million, compared with a TTM value of $266.7 million through Mar 2026, up 86983107.71%, and an annual FY2025 reading of $89.6 million, up 2734.48% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Shares Outstanding (Weighted Average) for 6 consecutive years, with $266.7 million as the latest value for Q1 2026.
- Shares Outstanding (Weighted Average) reached $266.7 million in Q1 2026 per DRUG's latest filing, up from $89.6 million in the prior quarter.
- Across five years, Shares Outstanding (Weighted Average) topped out at $266.7 million in Q1 2026 and bottomed at $306.64 in Q1 2025.
- Average Shares Outstanding (Weighted Average) over 5 years is $60.8 million, with a median of $3.0 million recorded in 2023.
- Year-over-year, Shares Outstanding (Weighted Average) grew 4.3% in 2023 and then skyrocketed 86983107.71% in 2026.
- Bright Minds Biosciences' Shares Outstanding (Weighted Average) stood at $2.7 million in 2022, then increased by 4.3% to $2.8 million in 2023, then grew by 12.29% to $3.2 million in 2024, then skyrocketed by 2734.48% to $89.6 million in 2025, then soared by 197.83% to $266.7 million in 2026.
- Per Business Quant, the three most recent readings for DRUG's Shares Outstanding (Weighted Average) are $266.7 million (Q1 2026), $89.6 million (Q3 2025), and $306.64 (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 177,333.76 Bn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 185,491.37 Bn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 100.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 55.66 Bn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 118.76 Bn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 254.10 Mn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 104.00 Mn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.04 Bn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 132.89 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 266.73 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 266.73 Mn |
| Dec 31, 2025 | 5.57 Mn |
| Sep 30, 2025 | 89.56 Mn |
| Jun 30, 2025 | 64.89 Mn |
| Mar 31, 2025 | 306.64 |
| Dec 31, 2024 | 7.16 |
| Sep 30, 2024 | 124.62 |
| Jun 30, 2024 | 36.56 |
| Mar 31, 2024 | 400.74 |
| Dec 31, 2023 | 2.82 Mn |
| Sep 30, 2023 | 2.81 Mn |
| Jun 30, 2023 | 1,176.23 |
| Mar 31, 2023 | 406.83 |
| Dec 31, 2022 | 478.86 |
| Sep 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 3,960.92 |
| Mar 31, 2022 | 623.69 |
| Dec 31, 2021 | 325.27 |
| Sep 30, 2021 | 1.88 Mn |
| Jun 30, 2021 | 585.74 |
| Mar 31, 2021 | 276.53 |
| Dec 31, 2020 | 92.05 |
| Sep 30, 2020 | 711,932.94 |